{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T15:10:01Z","timestamp":1700406601247},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"vor","delay-in-days":1895,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since the early 1990s ring\u2010substituted derivatives of amphetamine have been abused widely in the Republic of Ireland. The main ring\u2010substituted amphetamines being abused include methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA) and methylenedioxyethamphetamine (MDEA). A newer illicit synthetic analogue, which has been seized to a lesser extent by Irish police, is N\u2010methyl\u20101\u2010(3,4\u2010methylenedioxyphenyl)\u20102\u2010butanamine (MBDB). The work presented here involved the determination of the type of ring\u2010substituted amphetamines being abused by a group of recovering opiate abusers participating in a methadone maintenance programme in a Dublin Drug Rehabilitation Centre. Urine samples which tested positive for amphetamines and ring\u2010substituted amphetamines via EMIT immunoassay were subjected to further analysis using GC\u2010MS with MBTFA flash derivatization. It was found that the methylenedioxypropanamines were being abused, as was amphetamine itself. However, no abuse of methylenedioxybutanamines or thioamphetamines was observed.<\/jats:p>","DOI":"10.1080\/13556210020040262","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:08:03Z","timestamp":1027699683000},"page":"177-181","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland"],"prefix":"10.1111","volume":"6","author":[{"given":"P.","family":"Kavanagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Feely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Meegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Burdett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cber.189102401115"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cber.19100430126"},{"key":"e_1_2_1_4_2","unstructured":"E. Merck of Darmstadt assignee. Patent. Germany patent 274 350.1914 May 16."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(98)00008-5"},{"key":"e_1_2_1_6_2","first-page":"107","article-title":"Adverse reactions with 3,4\u2010methylenedioxymethamphetamine (MDMA; \u201cEcstasy\u201d","volume":"15","author":"McCann UD","year":"1996","journal-title":"Drug Experience"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04329-3"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(96)02095-6"},{"key":"e_1_2_1_9_2","first-page":"241","article-title":"MDEA related death in Crete: a case report and literature review","volume":"39","author":"Tsatsakis AM","year":"1997","journal-title":"Vet Hum Toxicol"},{"key":"e_1_2_1_10_2","unstructured":"http:\/\/www.incb.org\/e\/conv\/1971"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1986.10472362"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09595230096093","article-title":"Use of non\u2010prescribed methadone and other illicit drugs during methadone maintenance treatment","volume":"9","author":"Best D","year":"2000","journal-title":"Drug Alcohol Rev"},{"key":"e_1_2_1_13_2","first-page":"18","article-title":"Detection of benzodiazepine abuse in opiate addicts","volume":"91","author":"Browne R","year":"1998","journal-title":"Irish Med J"},{"key":"e_1_2_1_14_2","volume-title":"Facts about drug abuse in Ireland","author":"Corrigan D.","year":"1991"},{"key":"e_1_2_1_15_2","volume-title":"National drug treatment reporting system statistical bulletin","author":"O'Brien M","year":"2000"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199608000-00027"},{"key":"e_1_2_1_17_2","unstructured":"An Garda Siochana Annual Report 1998:Drugs offences:92\u201396."},{"issue":"2","key":"e_1_2_1_18_2","first-page":"133","article-title":"Identification of ecstasy in complex matrices using near\u2010infrared spectroscopy","volume":"10","author":"Sonder mann NK","journal-title":"Forens Sei Int l"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(96)02089-0"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1211\/146080899128734316"},{"key":"e_1_2_1_21_2","volume-title":"Report on the risk assessment of 4\u2010MTA in the framework of the joint action on new synthetic drugs","author":"EMCDDA","year":"1999"},{"key":"e_1_2_1_22_2","volume-title":"The chemistry of mind\u2010altering drugs: history pharmacology and cultural context","author":"Perrine DM.","year":"1996"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/20.6.432"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F13556210020040262","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/13556210020040262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T14:49:29Z","timestamp":1700405369000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/13556210020040262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1080\/13556210020040262"],"URL":"https:\/\/doi.org\/10.1080\/13556210020040262","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]},"assertion":[{"value":"2006-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}